Headlines

Tilray Already 6% Down, Almost Five Hours Before The NASDAQ Open

(VIANEWS) – The NASDAQ opens in less than five hours and Tilray‘s pre-market value is already 6.3% down.

Tilray’s last close was $2.38, 53.52% below its 52-week high of $5.12.

The last session, NASDAQ finished with Tilray (TLRY) sliding 5.93% to $2.38. NASDAQ slid 0.43% to $14,283.91, following the last session’s downward trend on what was a somewhat bearish trend trading session.

About Tilray

Tilray Brands, Inc. engages in the research, cultivation, processing, and distribution of medical cannabis products in Canada, the United States, Europe, Australia, New Zealand, Latin America, and internationally. The company operates through four segments: Cannabis Business, Distribution Business, Beverage Alcohol Business, and Wellness Business. It also offers medical and adult-use cannabis products; purchases and resells pharmaceutical and wellness products; and produces, markets, sells, and distributes beverage alcohol products, and hemp-based food and other wellness products. In addition, the company offers its products under the Tilray, Aphria, Broken Coast, Symbios, B!NGO, The Batch, Dubon, Good Supply, Solei, Chowie Wowie, Canaca, RIFF, SweetWater, Breckenridge Distillery, Alpine Beer Company, and Green Flash brands. It sells its products to retailers, wholesalers, patients, physicians, hospitals, pharmacies, researchers, and governments, as well as direct to consumers. The company was formerly known as Tilray, Inc. and changed its name to Tilray Brands, Inc. in January 2022. Tilray Brands, Inc. is headquartered in Leamington, Canada.

Earnings Per Share

As for profitability, Tilray has a trailing twelve months EPS of $-3.1.

Growth Estimates Quarters

The company’s growth estimates for the current quarter and the next is 53.8% and 54.5%, respectively.

Volume

Today’s last reported volume for Tilray is 31560145 which is 12.01% below its average volume of 18752300.

Earnings Before Interest, Taxes, Depreciation, and Amortization

Tilray’s EBITDA is 2.77.

Sales Growth

Tilray’s sales growth for the current quarter is 13.4%.

More news about Tilray (TLRY).

Leave a Reply

Your email address will not be published. Required fields are marked *